Table 2.
Secondary outcomes analysis.
| Outcomes | Total | Pre-WMCPC | Post-WMCPC | p-Value |
|---|---|---|---|---|
| (n = 482) | (n = 511) | |||
| Time from referral to first clinic visit (days) | (n = 993) | ˂0.001 | ||
| Median (minimum, maximum) | 8 (0, 374) | 10 (0, 217) | 8.8 (0, 374) | |
| Unknown | 116 | 114 | ||
| Time from first visit to biopsy (days) | (n =580) | 0.022 | ||
| Median (range) | 12 (0, 567) | 14 (0, 567) | 8 (0, 245) | |
| Unknown | 161 | 88 | 73 | |
| Time to curative surgery | (n = 149) | (n = 85) | (n = 64) | 0.48 |
| Median (range) | 28 (5, 749) | 34 (5, 145) | 26 (6, 749) | |
| Unknown | 41 | 39 | 2 | |
| Time to neoadjuvant chemotherapy/ chemo-radiotherapy (days) |
(n = 33) | (n = 11) | (n = 22) | |
| Median (range) | 34 (16, 208) | 33 (16, 121) | 34 (17, 208) | 0.93 |
| Unknown | 1 | 1 | 0 | |
| Time to adjuvant chemotherapy (days) | (n = 18) | (n = 5) | (n = 13) | |
| Median (range) | 45 (23, 108) | 44 (35, 45) | 51 (23, 108) | 0.25 |
| Time to palliative chemotherapy (days) | (n = 300) | (n = 153) | (n = 147) | |
| Median (range) | 34 (11, 670) | 35 (11, 605) | 32 (11, 670) | 0.3 |
| Unknown | 58 | 22 | ||
| Time to palliative chemo-radiotherapy (days) | (n = 22) | (n = 18) | (n = 4) | |
| Median (range) | 31.5 (6, 889) | 31.5 (6, 97) | 30.5 (17, 889) | 0.074 |
| Unknown | 4 | 4 | 0 | |
| Time from first clinic to first oncology treatment at PM (days) | (n = 583) | (n = 292) | (n = 291) | |
| Median (range) | 25 (0, 886) | 26 (0, 721) | 23 (1, 886) | 0.14 |
| Unknown | 84 | 14 | 70 |
WMCPC: Wallace McCain Centre for Pancreatic Cancer; ECOG PS: Eastern Cooperative Oncology Group Performance Status; PM: Princess Margaret Cancer Centre. Note: Treatment timing may vary significantly due to the complex nature of the disease and the high likelihood of complications, which can lead to delays in initiating treatments. An improvement in time to first assessment and biopsy were demonstrated.